Latest Leadership Transition News

Proteomics International Laboratories announces the planned retirement of its founder and Managing Director, Dr Richard Lipscombe, in February 2026, marking a pivotal leadership transition as the company seeks a new CEO to drive its next growth phase.

King River Resources has appointed seasoned geologist and executive Graham Gadsby as Managing Director, aiming to leverage his proven track record in gold exploration and operational turnarounds to drive the company’s future growth.

SunRice reported steady FY25 financials with improved profitability despite revenue pressure, while advancing its 2030 Growth Strategy amid industry headwinds and leadership transition.

Green360 Technologies announces CEO Bojan Bogunovic's resignation effective October 31, with Executive Chairman Aaron Banks stepping in to lead daily operations during a pivotal growth phase.

Iress Limited has appointed Andrew Russell as its new Group CEO, marking a strategic leadership shift following a major company transformation. Russell’s extensive fintech experience positions him to lead Iress into a product and client-focused future.

Jatcorp announces the immediate resignation of CEO Sunny Liang, appointing Executive Director Dr Sean Li as acting CEO during the search for a permanent replacement.

Collins Foods delivered record $1.5 billion revenue in FY25, pivoting to focus on KFC growth in Australia and Germany while exiting Taco Bell. Despite impairments and wage remediation costs, the company targets strong profit growth in FY26.

Eneco Refresh Limited has appointed Christerpher Conyers as CEO following his instrumental role in returning the company to profitability. His leadership marks a new chapter focused on sustaining growth and operational efficiency.

Coventry Group Ltd has appointed Nik Alpert as Managing Director, marking a key leadership transition with no changes to his existing remuneration package.

Golden State Mining has raised $1.5 million through a strategic share placement to fund its gold exploration projects and potential acquisitions, alongside notable board changes signaling a new chapter for the company.

Opthea Limited reported a 26% reduction in net loss for FY2025 despite discontinuing its wet AMD drug after failed Phase III trials. The company settled its Development Funding Agreement with investors, securing liquidity and planning a strategic pivot.

Elanor Investors Group reported a substantial $157.8 million net loss for FY24 amid asset devaluations and debt covenant breaches, prompting a strategic recapitalisation and leadership transition.